Rheumatoid arthritis drug cuts coronavirus deaths in clinical trial, Eli Lilly says
October 09 2020, 08:00
In the clinical trial patients are given a combination of baricitinib and remdesivir.
In the clinical trial patients are given a combination of baricitinib and remdesivir.
Source:
FOX News